Kidney transplantation remains the most effective treatment for end-stage kidney disease; however, long-term graft survival is constrained by rejection and chronic graft injury, and donor shortages continue to drive interest in xenotransplantation. The complement system is increasingly recognized both as a terminal eff...
Y. Kakuta, Shuji Miyagawa, Shunsuke Mori et al.· Frontiers in Immunology· 0 citations
Arrhythmogenic cardiomyopathy (ACM) is a hereditary disease caused by desmosomal haploinsufficiency and associated with heart failure and sudden cardiac death. Disease-modifying therapies targeting the underlying molecular mechanisms remain limited. Isogenic-induced pluripotent stem cell–derived cardiomyocytes...
Cong-Cong Sun, Hiroyuki Inoue, Shuichiro Higo et al.· Stem Cell Research & The...· 0 citations
BACKGROUND
Diastolic dysfunction is a recognized chronic allograft complication, and a restrictive left ventricular filling pattern is associated with adverse outcomes. However, the underlying pathophysiological mechanisms remain unclear.
METHODS AND RESULTS
This study included 32 heart transplant recipients with a n...
Kosuke Takahari, Tatsuya Shiraki, H. Kioka et al.· Circulation Journal· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.